Catalysts for Teva Pharmaceuticals USA Inc
453 tracked
Dec 3, 2021
approval
ACTIQ (FENTANYL CITRATE) — FDA approval
Teva Pharmaceuticals USA Inc
→
Nov 10, 2021
approval
CLOZAPINE — FDA approval
Teva Pharmaceuticals USA Inc
→
Nov 10, 2021
approval
CLOZAPINE — FDA approval
Teva Pharmaceuticals USA Inc
→
Nov 8, 2021
approval
CLARAVIS (ISOTRETINOIN) — FDA approval
Teva Pharmaceuticals USA Inc
→
Nov 8, 2021
approval
CLARAVIS (ISOTRETINOIN) — FDA approval
Teva Pharmaceuticals USA Inc
→
Oct 8, 2021
approval
CLARAVIS (ISOTRETINOIN) — FDA approval
Teva Pharmaceuticals USA Inc
→
Oct 8, 2021
approval
CLARAVIS (ISOTRETINOIN) — FDA approval
Teva Pharmaceuticals USA Inc
→
Aug 4, 2021
approval
MORPHINE SULFATE — FDA approval
Teva Pharmaceuticals USA Inc
→
Jul 29, 2021
approval
CLOZAPINE — FDA approval
Teva Pharmaceuticals USA Inc
→
Jul 29, 2021
approval
CLOZAPINE — FDA approval
Teva Pharmaceuticals USA Inc
→
Apr 29, 2021
approval
MORPHINE SULFATE — FDA approval
Teva Pharmaceuticals USA Inc
→
Mar 4, 2021
approval
MORPHINE SULFATE — FDA approval
Teva Pharmaceuticals USA Inc
→
Mar 4, 2021
approval
FENTORA (FENTANYL CITRATE) — FDA approval
Teva Pharmaceuticals USA Inc
→
Mar 4, 2021
approval
BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE (BUPRENORPHINE HYDROCHLORIDE) — FDA approval
Teva Pharmaceuticals USA Inc
→
Mar 4, 2021
approval
ACTIQ (FENTANYL CITRATE) — FDA approval
Teva Pharmaceuticals USA Inc
→
Feb 18, 2021
approval
CLOZAPINE — FDA approval
Teva Pharmaceuticals USA Inc
→
Feb 18, 2021
approval
CLOZAPINE — FDA approval
Teva Pharmaceuticals USA Inc
→
Feb 2, 2021
approval
NIZORAL ANTI-DANDRUFF (KETOCONAZOLE) — FDA approval
Teva Pharmaceuticals USA Inc
→
Jan 26, 2021
approval
VIGABATRIN — FDA approval
Teva Pharmaceuticals USA Inc
→
Jan 26, 2021
approval
VIGABATRIN — FDA approval
Teva Pharmaceuticals USA Inc
→
Dec 23, 2020
approval
FENTORA (FENTANYL CITRATE) — FDA approval
Teva Pharmaceuticals USA Inc
→
Dec 23, 2020
approval
ACTIQ (FENTANYL CITRATE) — FDA approval
Teva Pharmaceuticals USA Inc
→
Dec 9, 2020
approval
CLARAVIS (ISOTRETINOIN) — FDA approval
Teva Pharmaceuticals USA Inc
→
Dec 9, 2020
approval
CLARAVIS (ISOTRETINOIN) — FDA approval
Teva Pharmaceuticals USA Inc
→
Oct 2, 2020
approval
VIGABATRIN — FDA approval
Teva Pharmaceuticals USA Inc
→
Oct 2, 2020
approval
VIGABATRIN — FDA approval
Teva Pharmaceuticals USA Inc
→
Aug 3, 2020
approval
VIGABATRIN — FDA approval
Teva Pharmaceuticals USA Inc
→
Aug 3, 2020
approval
VIGABATRIN — FDA approval
Teva Pharmaceuticals USA Inc
→
Apr 20, 2020
approval
NIZORAL ANTI-DANDRUFF (KETOCONAZOLE) — FDA approval
Teva Pharmaceuticals USA Inc
→
Apr 17, 2020
approval
VIGABATRIN — FDA approval
Teva Pharmaceuticals USA Inc
→